247 related articles for article (PubMed ID: 17697672)
1. A gold(I) phosphine complex selectively induces apoptosis in breast cancer cells: implications for anticancer therapeutics targeted to mitochondria.
Rackham O; Nichols SJ; Leedman PJ; Berners-Price SJ; Filipovska A
Biochem Pharmacol; 2007 Oct; 74(7):992-1002. PubMed ID: 17697672
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of gold(I) phosphine complexes containing the 2-BrC
Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
Eur J Med Chem; 2018 Feb; 145():291-301. PubMed ID: 29331752
[TBL] [Abstract][Full Text] [Related]
3. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
[TBL] [Abstract][Full Text] [Related]
4. Gold(I) chloride adducts of 1,3-bis(di-2-pyridylphosphino)propane: synthesis, structural studies and antitumour activity.
Humphreys AS; Filipovska A; Berners-Price SJ; Koutsantonis GA; Skelton BW; White AH
Dalton Trans; 2007 Nov; (43):4943-50. PubMed ID: 17992279
[TBL] [Abstract][Full Text] [Related]
5. Chemical biology of anticancer gold(III) and gold(I) complexes.
Zou T; Lum CT; Lok CN; Zhang JJ; Che CM
Chem Soc Rev; 2015 Dec; 44(24):8786-801. PubMed ID: 25868756
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer gold(I) phosphine complexes: Cyclic trimers and tetramers containing the P-Au-P moiety.
Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
J Inorg Biochem; 2017 Oct; 175():1-8. PubMed ID: 28686996
[TBL] [Abstract][Full Text] [Related]
7. Phosphine-gold(I) compounds as anticancer agents: general description and mechanisms of action.
Lima JC; Rodriguez L
Anticancer Agents Med Chem; 2011 Dec; 11(10):921-8. PubMed ID: 21864238
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer.
Gambini V; Tilio M; Maina EW; Andreani C; Bartolacci C; Wang J; Iezzi M; Ferraro S; Ramadori AT; Simon OC; Pucciarelli S; Wu G; Dou QP; Marchini C; Galassi R; Amici A
Eur J Med Chem; 2018 Jul; 155():418-427. PubMed ID: 29906688
[TBL] [Abstract][Full Text] [Related]
9. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
[TBL] [Abstract][Full Text] [Related]
10. Gold(I) complexes of water-soluble diphos-type ligands: synthesis, anticancer activity, apoptosis and thioredoxin reductase inhibition.
Wetzel C; Kunz PC; Kassack MU; Hamacher A; Böhler P; Watjen W; Ott I; Rubbiani R; Spingler B
Dalton Trans; 2011 Sep; 40(36):9212-20. PubMed ID: 21826354
[TBL] [Abstract][Full Text] [Related]
11. In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake.
Liu JJ; Galettis P; Farr A; Maharaj L; Samarasinha H; McGechan AC; Baguley BC; Bowen RJ; Berners-Price SJ; McKeage MJ
J Inorg Biochem; 2008 Feb; 102(2):303-10. PubMed ID: 18029019
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, properties, and antitumor effects of a new mixed phosphine gold(I) compound in human colon cancer cells.
Lupidi G; Avenali L; Bramucci M; Quassinti L; Pettinari R; Khalife HK; Gali-Muhtasib H; Marchetti F; Pettinari C
J Inorg Biochem; 2013 Jul; 124():78-87. PubMed ID: 23632460
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.
Hickey JL; Ruhayel RA; Barnard PJ; Baker MV; Berners-Price SJ; Filipovska A
J Am Chem Soc; 2008 Sep; 130(38):12570-1. PubMed ID: 18729360
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
[TBL] [Abstract][Full Text] [Related]
15. Amides of gold(I) diphosphines prepared from N-heterocyclic sources and their in vitro and in vivo screening for anticancer activity.
Horvath UE; Dobrzańska L; Strasser CE; Bouwer Neé Potgieter W; Joone G; van Rensburg CE; Cronje S; Raubenheimer HG
J Inorg Biochem; 2012 Jun; 111():80-90. PubMed ID: 22498717
[TBL] [Abstract][Full Text] [Related]
16. Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma.
Sze JH; Raninga PV; Nakamura K; Casey M; Khanna KK; Berners-Price SJ; Di Trapani G; Tonissen KF
Redox Biol; 2020 Jan; 28():101310. PubMed ID: 31514052
[TBL] [Abstract][Full Text] [Related]
17. Water-Soluble Gold(III)-Metformin Complex Alters Mitochondrial Bioenergetics in Breast Cancer Cells.
Hyun Kim J; Ofori S; Mertens RT; Parkin S; Awuah SG
ChemMedChem; 2021 Oct; 16(20):3222-3230. PubMed ID: 34159760
[TBL] [Abstract][Full Text] [Related]
18. Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents.
Chaves JDS; Tunes LG; de J Franco CH; Francisco TM; Corrêa CC; Murta SMF; Monte-Neto RL; Silva H; Fontes APS; de Almeida MV
Eur J Med Chem; 2017 Feb; 127():727-739. PubMed ID: 27823888
[TBL] [Abstract][Full Text] [Related]
19. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
Li CK; Sun RW; Kui SC; Zhu N; Che CM
Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
[TBL] [Abstract][Full Text] [Related]
20. Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases.
Urig S; Fritz-Wolf K; Réau R; Herold-Mende C; Tóth K; Davioud-Charvet E; Becker K
Angew Chem Int Ed Engl; 2006 Mar; 45(12):1881-6. PubMed ID: 16493712
[No Abstract] [Full Text] [Related]
[Next] [New Search]